Literature DB >> 28800318

MiR-513c suppresses neuroblastoma cell migration, invasion, and proliferation through direct targeting glutaminase (GLS).

Hong-Liang Xia1,1, Yao Lv2,1, Chun-Wei Xu3, Ming-Cui Fu1, Ting Zhang1, Xiang-Ming Yan1, Shu Dai1, Qian-Wei Xiong1, Yun Zhou1, Jian Wang1, Xu Cao1.   

Abstract

Neuroblastoma is a malignancy [corrected] of childhood and accounts for 7-10% of childhood cancers, leading to approximately 15% of pediatric cancer deaths. MicroRNAs (miRNAs) are a family of short (about 18-25 nucleotides), noncoding and single stranded endogenous RNAs, which complementarily bind to the 3' untranslated regions of their target genes. Recently, glutamine metabolism has been recognized as an important nutrition source for tumor cells, and hence targeting glutamine metabolism could benefit to development of anti-cancer agents. In this study, we investigate the roles of miR-513c in human neuroblastoma. We report miR-513c is significantly downregulated in human neuroblastoma tissues compared with their adjacent normal tissues. Moreover, miR-513c is significantly downregulated in neuroblastoma cell lines compared with normal neuroblast cells. Overexpression of miR-513c suppresses neuroblastoma cells' migration, invasion, and proliferation. We demonstrate the glutaminase (GLS) is a direct target of miR-513c in human neuroblastoma cells. In addition, we found restoration of GLS expression recovered the neuroblastoma cells' migration, invasion, and proliferation. In summary, this study illustrates a miR-513c mediated neuroblastoma cells suppression, providing a new aspect on the miRNA-based therapeutic approach for the treatments of neuroblastoma.

Entities:  

Keywords:  MiR-513c; glutaminase; invasion; migration; neuroblastoma; proliferation

Mesh:

Substances:

Year:  2017        PMID: 28800318     DOI: 10.3233/CBM-170577

Source DB:  PubMed          Journal:  Cancer Biomark        ISSN: 1574-0153            Impact factor:   4.388


  12 in total

1.  Inhibition of GLS suppresses proliferation and promotes apoptosis in prostate cancer.

Authors:  Junfeng Zhang; Shiyu Mao; Yadong Guo; Yuan Wu; Xudong Yao; Yong Huang
Journal:  Biosci Rep       Date:  2019-06-25       Impact factor: 3.840

2.  The Potential Role of Selected miRNA in Uveal Melanoma Primary Tumors as Early Biomarkers of Disease Progression.

Authors:  Joanna Patrycja Wróblewska; Michał Stefan Lach; Adam Ustaszewski; Katarzyna Kulcenty; Matthew Ibbs; Inga Jagiełło; Wiktoria Maria Suchorska; Andrzej Marszałek
Journal:  Genes (Basel)       Date:  2020-03-02       Impact factor: 4.096

Review 3.  Non-Coding RNAs as Key Regulators of Glutaminolysis in Cancer.

Authors:  Yunuen Ortiz-Pedraza; J Omar Muñoz-Bello; Leslie Olmedo-Nieva; Adriana Contreras-Paredes; Imelda Martínez-Ramírez; Elizabeth Langley; Marcela Lizano
Journal:  Int J Mol Sci       Date:  2020-04-20       Impact factor: 5.923

Review 4.  Non-Coding RNAs Participate in the Pathogenesis of Neuroblastoma.

Authors:  Omidvar Rezaei; Kasra Honarmand Tamizkar; Mohammadreza Hajiesmaeili; Mohammad Taheri; Soudeh Ghafouri-Fard
Journal:  Front Oncol       Date:  2021-02-24       Impact factor: 6.244

5.  TNRC6C-AS1 Promotes Thyroid Cancer Progression by Upregulating LPAR5 via miR-513c-5p.

Authors:  Chuanming Tong; Chuan Wang; Yajie Wang; Xiongsheng Xiao
Journal:  Cancer Manag Res       Date:  2021-08-06       Impact factor: 3.989

6.  The expression of miR-513c and miR-3163 was downregulated in tumor tissues compared with normal adjacent tissue of patients with breast cancer.

Authors:  Soheila Delgir; Khandan Ilkhani; Asma Safi; Yazdan Rahmati; Vahid Montazari; Zahra Zaynali-Khasraghi; Farhad Seif; Milad Bastami; Mohammad Reza Alivand
Journal:  BMC Med Genomics       Date:  2021-07-07       Impact factor: 3.063

7.  SNHG16 promotes tumorigenesis and cisplatin resistance by regulating miR-338-3p/PLK4 pathway in neuroblastoma cells.

Authors:  Zhaoying Xu; Yongfa Sun; Danfeng Wang; Huifang Sun; Xiaojun Liu
Journal:  Cancer Cell Int       Date:  2020-06-12       Impact factor: 5.722

8.  Regulation of hepatic glutamine metabolism by miR-122.

Authors:  Dipanwita Sengupta; Teresa Cassel; Kun-Yu Teng; Mona Aljuhani; Vivek K Chowdhary; Peng Hu; Xiaoli Zhang; Teresa W-M Fan; Kalpana Ghoshal
Journal:  Mol Metab       Date:  2020-01-09       Impact factor: 7.422

9.  MicroRNA-145 overexpression inhibits neuroblastoma tumorigenesis in vitro and in vivo.

Authors:  Jing Zhao; Kai Zhou; Liang Ma; Huanyu Zhang
Journal:  Bioengineered       Date:  2020-12       Impact factor: 3.269

10.  Glutaminase isoforms expression switches microRNA levels and oxidative status in glioblastoma cells.

Authors:  Juan de Los Santos-Jiménez; José A Campos-Sandoval; Clara Márquez-Torres; Nieves Urbano-Polo; David Brøndegaard; Mercedes Martín-Rufián; Carolina Lobo; Ana Peñalver; María C Gómez-García; Janet Martín-Campos; Carolina Cardona; Laura Castilla; Felipe da Costa Souza; Tzuling Cheng; Juan A Segura; Francisco J Alonso; Rui Curi; Alison Colquhoun; Ralph J DeBerardinis; Javier Márquez; José M Matés
Journal:  J Biomed Sci       Date:  2021-02-20       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.